PEDIATRICS (PEDS) -> PEDS - Heart Transplantation Abstracts

148 - Development and Utility of a Novel Post-Operative Pediatric Heart Transplant Clinical Pathway

Presentation Number
148
Speakers
Session Name
SESSION 41 - ORAL: New Insights in Pediatric Heart and Lung Transplant
Date
Thu, Apr 23, 2020
Time
04:15 PM - 06:00 PM
Authors

Previous ePresentation
141 - CD26/DPP4 Inhibitor: A Novel Prophylactic Drug for Chronic Allograft Dysfunction after Clinical Lung Transplantation

Next ePresentations
161 - The Impact of Local Heart Allocation on Post-Transplant Survival
163 - Early IVUS-Guided Selection for Non-Invasive Cardiac Allograft Vasculopathy (CAV) Screening in Heart Transplant Recipients
168 - Assessment of Cardiac Allograft Vasculopathy from Oct Images: Automated Analysis is as Good as Expert-Guided Approach
177 - Outcomes of HIV-Positive Patients Post Cardiac Transplantation
178 - Lung Transplant in HIV-Infected Patients. Single Centre Experience
183 - Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results from the Outcomes Allomap® Registry
187 - Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients - A Pediatric Heart Transplant Society Study
191 - Mitochondrial Transplantation for Myocardial Protection in Ex-Situ Perfused Hearts Donated after Cardio-Circulatory Death
196 - Mitochondrial Function is Impaired in Heart Transplant Patients with Cardiac Allograft Vasculopathy
197 - The Canonical Wnt Pathway in the Pathogenesis of Cardiac Allograft Vasculopathy